Sélectionner une page

Jean-Yves BONNEFOY

President & CEO

Development of new regenerative medicines

Anagenesis Biotechnologies is a preclinical-stage stem cell-based company focused on developing novel treatments for muscle degenerative diseases and type 2 diabetes through two complementary, cutting-edge approaches.

It develops paraxial mesoderm-derived lineages (striated muscle, brown fat, cartilage, bone, dermis & endothelial cells) to generate new treatments against human diseases.

Thanks to its unique technology, able to produce paraxial mesoderm from pluripotent stem cells, Anagenesis produces muscle progenitors highly enriched in muscle adult stem cells, i.e. satellite cells. These cells are essential to muscle regeneration. Drugs acting on satellite cells, therefore, represent an innovative approach to treat both genetic and chronic muscle diseases.